Healthpeak Properties, Inc.

CFD Mechanics: What a DOC Position Represents

A DOC CFD on CoinUnited provides price exposure that tracks the underlying Healthpeak Properties share price. It is not an equity stake. Opening a long or short position confers no shareholding, no voting rights, and no entitlement to dividend distributions.

For a REIT such as Healthpeak, where the IRS-mandated 90% income distribution requirement produces a materially higher dividend yield than most equities, this distinction has real economic significance. The dividend cash flow that accrues to a direct shareholder does not transfer to a CFD holder; instead, traders are exposed solely to price movement in the underlying share.

Healthpeak declared a monthly dividend of $0.10167 per share for each month of Q4 2026 — October, November, and December — implying an annualised rate of approximately $1.22 per share, which underscores the scale of income that equity holders receive and CFD holders do not.

Session Schedule and Weekend Gap Risk

The DOC instrument follows a scheduled trading session aligned with U.S. equity market hours. It is closed at weekends and observes the applicable U.S. market holiday calendar. The full session schedule and holiday calendar are displayed on the platform before a position is opened.

Weekend gap risk warrants specific attention for this instrument. Material news, Federal Reserve communications, earnings pre-announcements, sector-level policy changes affecting healthcare reimbursement, or broad credit-market moves can emerge when the market is closed. When trading resumes, the opening price may differ substantially from Friday's close.

DOC's recent intraday range illustrates the pace at which price can move: the stock fell 1.49% on October 21, then reversed to gain 2.38% on October 22, closing at $18.92 — all within two consecutive sessions.

Stop-loss orders placed at a specific level cannot guarantee execution at that level if price gaps through it. Traders holding positions into a weekend session closure should factor this into their sizing decisions.

Worked Leverage Scenario

The maximum leverage for the DOC CFD is 1000x, subject to product, jurisdiction, and account eligibility. Leverage amplifies both gains and losses proportionally; the following example illustrates the mechanics.

Step by step: $50 margin multiplied by 1000x leverage equals $50,000 of notional exposure. A 1% adverse move in DOC's share price produces a $500 loss ($50,000 × 0.01). That $500 loss exceeds the $50 margin posted by a factor of ten, triggering liquidation well before the move is complete.

With DOC trading at $18.92 as of October 22, 2026 — already approximately 18.25% below its $22.95 52-week high — the stock carries meaningful directional volatility that compounds this liquidation risk.

The same arithmetic applies symmetrically to short positions: a 1% price increase against a short generates an equivalent loss relative to margin. At 1000x leverage, the effective liquidation threshold is a fraction of a percent of adverse movement from entry, depending on the platform's margin maintenance requirements.

This is the primary mechanical risk of leveraged CFD trading and is not specific to DOC, but it is accentuated by the event calendar Healthpeak carries.

Position Sizing Considerations

Healthpeak's share price is sensitive to several recurring event types that can produce rapid, gapped moves:

• -FOMC meetings: Rate-sensitive REITs respond sharply to Federal Reserve communications. A hawkish surprise can compress REIT valuations quickly across the sector.
• -Quarterly earnings releases: Funds from operations (FFO) guidance, occupancy data, and leasing activity in the lab and outpatient segments can move the stock materially at the open following an after-hours release.

Healthpeak's most recent quarter delivered revenue of $771.58 million, up 11.1% year over year, with EPS of $0.08 beating the $0.03 consensus estimate — results of this magnitude routinely drive sharp post-announcement price moves.

• -Ex-dividend dates: Share prices typically adjust downward at the ex-dividend date by an amount approximating the dividend. With Q4 2026 payment dates of October 30, November 25, and December 30 confirmed, traders should note each scheduled ex-dividend date on the instrument calendar. CFD holders are not entitled to the dividend but are exposed to the price adjustment.

Position sizing should account for the possibility that stop-loss orders may not execute at the specified level during fast markets around these events. Reducing notional exposure ahead of known event dates is one way traders manage this; the appropriate approach depends on individual risk tolerance and is not a recommendation.

Trading Fees

Trading fees on CoinUnited are not zero at the standard tier. Fees follow a tiered structure based on 30-day contract volume, reaching 0.000% only at VIP 9. For traders running high-frequency or short-duration positions in DOC, fees accumulate across each round trip and should be factored into expected return calculations before sizing a position.

This is particularly relevant given DOC's recent session-to-session swings, which may tempt active positioning.

The full fee schedule is published at coinunited.io/en/account/trading-fees.

Traders interested in the broader context of retail access to leveraged equity derivatives can review current developments in prop trading and retail derivatives access.

Healthpeak Properties occupies a distinct position within a small group of large-cap U.S. healthcare REITs, with Ventas, Inc. (VTR) and Welltower Inc. (WELL) representing two of its most directly comparable listed peers.

Notably, a September 2026 healthcare-REIT analysis identified Healthcare Realty Trust (HR) as DOC's closest operating benchmark, given the significant overlap in medical-office and life-science exposure between the two companies.

All three companies own diversified healthcare real estate portfolios, but they differ in segment weighting, scale, and strategic emphasis — differences that matter to traders assessing relative valuation, sector rotation flows, and risk exposure.

Scale and Index Weight

Among U.S. healthcare REITs, Welltower commands the largest market capitalization and is generally viewed as the sector bellwether. Its index weight means that institutional flows tracking healthcare REIT benchmarks tend to concentrate there first.

Healthpeak, following its merger with Physicians Realty Trust, positions itself as a mid-to-large peer, meaningful in absolute terms but carrying secondary index weight relative to Welltower. That positioning has practical implications: thinner institutional demand at the margin can translate into wider bid-ask spreads and more volatile price responses to sector-level news.

Ventas sits in a comparable size tier to Healthpeak, though its portfolio composition reflects a different strategic emphasis. Healthcare Realty Trust, while smaller, warrants particular attention from traders specifically evaluating the medical-office sub-sector.

Segment Differentiation

The companies diverge most clearly at the segment level.

Healthpeak's concentration in outpatient medical is its clearest differentiator from senior housing-heavy peers. Outpatient medical leases are typically longer-term, structured on triple-net or modified gross terms, and anchored by creditworthy health system tenants.

This produces more predictable cash flows but limits the operational upside that Welltower can capture as senior housing occupancy recovers from post-pandemic lows.

Healthpeak reported quarterly revenue of $771.58 million in its most recent filing — representing 11.1% year-over-year growth — with FY 2026 EPS guidance set at $1.73–$1.77, reflecting the relative stability of its outpatient-anchored cash flow profile.

Welltower's senior housing operating portfolio, by contrast, behaves more like an operating business than a traditional landlord arrangement: revenue and margins move directly with occupancy and expense trends, creating higher earnings volatility in both directions.

Life Science Overlap

Healthpeak's life-science segment creates a sub-sector overlap with Ventas, Healthcare Realty Trust, and Alexandria Real Estate Equities (ARE), the latter being the dedicated life-science REIT benchmark.

These companies compete for institutional tenants — pharmaceutical companies, biotech firms, and research institutions — in geographically clustered markets such as South San Francisco, San Diego, and Boston.

As of October 2026, certain of these markets have experienced elevated vacancy following a period of rapid development activity, a headwind that has weighed on life-science REIT valuations across the peer group and is a key variable differentiating DOC's earnings trajectory from outpatient-pure-play comparisons.

The shared life-science exposure between DOC and HR makes this vacancy dynamic particularly relevant when comparing the two.

Relative Valuation Metrics for Traders

Analyst consensus across the healthcare REIT peer group continues to be shaped primarily by the interest rate environment and the pace of senior housing occupancy recovery.

A standardised peer table comparing DOC, HR, VTR, and others on market capitalisation, FFO per share, leverage, occupancy, and total return is not available from verified October 2026 sources; traders should consult current filings and consensus databases directly for those figures. That said, three comparative metrics reported on a quarterly basis remain the key framework:

• -FFO (Funds from Operations) growth differentials: FFO is the REIT-standard earnings measure; relative growth rates signal which company is compounding its portfolio more efficiently.
• -NAV discount or premium: Healthcare REITs trade at varying spreads to estimated net asset value; a widening discount in DOC relative to peers can indicate relative underperformance or sector rotation away from its segment mix.
• -Segment-level occupancy trends: Outpatient medical occupancy stability versus senior housing recovery pace determines which peer's earnings revisions move higher in a given rate or macro environment.

For traders taking CFD price exposure to DOC through prop trading and derivatives platforms, understanding peer positioning clarifies the relative trade: DOC offers more stable but operationally less dynamic cash flows than Welltower, and more medical-real-estate concentration than Ventas, with its closest structural peer being Healthcare

Realty Trust. The life-science exposure shared by both DOC and HR creates a common headwind or tailwind depending on R&D investment cycles and sub-market vacancy trends.

Healthpeak Properties trades at the intersection of interest rate sensitivity, demographic trends, and healthcare sector dynamics, a combination that produces identifiable, analyzable price drivers for traders building a structured view on DOC.

Interest Rate Direction: The Dominant Macro Variable

As a REIT, Healthpeak is structurally sensitive to interest rate movements. Rising rates compress the present value of future cash flows, making dividend-paying real estate equities less competitive relative to risk-free fixed-income alternatives. Rate increases also raise the cost of debt that Healthpeak uses to finance property acquisitions and refinance existing obligations.

Both effects tend to pressure the share price.

Conversely, a falling rate environment typically re-rates REITs higher. When yields on bonds and money market instruments decline, income-generating equities such as healthcare REITs attract renewed allocation from yield-seeking investors. The direction and pace of rate moves, not simply the absolute level, drive the near-term trading range for DOC.

Wells Fargo's October 2026 price target reduction is a reminder that analyst reassessments can amplify or counteract broader rate-driven moves.

Demographic Tailwinds: The Structural Demand Argument

The aging of the U.S. baby boomer cohort provides a long-duration demand argument for outpatient medical and senior living facilities. As this population cohort moves through its seventies and eighties, utilization of physician offices, ambulatory surgical centers, and continuing care retirement communities is expected to increase.

October 2026 commentary specifically identified outpatient-care migration as a live catalyst, distinct from the longer-run demographic backdrop.

This demographic pressure supports occupancy assumptions in Healthpeak's outpatient medical and CCRC segments across market cycles, independently of short-term macroeconomic conditions. For traders with a medium-to-long horizon, this structural factor supports the thesis that demand for Healthpeak's property types will remain broadly supported.

Life-Science Segment: Cyclical Funding Sensitivity

The lab and life-science portion of Healthpeak's portfolio introduces a distinct cyclical risk layer. Demand for laboratory space in markets such as San Francisco and Boston is closely linked to biotech and pharmaceutical funding conditions, including venture capital activity, NIH budget allocations, and broader risk appetite for early-stage growth companies.

When funding contracts, tenant demand softens, vacancy rates rise, and rental growth slows. October 2026 analysis explicitly flagged weaker laboratory recovery as a risk capable of undermining Healthpeak's valuation case. Traders monitoring DOC should track biotech financing trends and NIH funding signals as leading indicators for this segment's performance.

Earnings and Financial Position: Near-Term Execution Signals

Healthpeak's Q2 2026 FFO of $0.46 per share exceeded analyst estimates of $0.44 and was accompanied by revenue of $771.6 million. Management maintained FY 2026 FFO guidance of $1.73–$1.77 per share, though consensus FY 2026 EPS of $1.77 represents a 3.8% decline from $1.84 in FY 2025.

The company's financial footing is supported by more than $3 billion of liquidity and approximately $1.29 billion in trailing-twelve-month free cash flow. A quarterly dividend of $0.10167 per share per month across Q4 2026 — equivalent to $1.22 annualized — reflects a payout ratio of roughly 70%, a level that analysts have cited as a positive for income-oriented positioning.

Quarterly earnings calls and analyst day presentations remain practical inputs for traders positioning around guidance confirmations or revisions.

Capital Recycling and Joint-Venture Execution

Beyond merger integration, October 2026 commentary identified capital-recycling discipline and joint-venture economics as distinct execution risks. The ability to rotate capital toward higher-yielding opportunities and structure partner arrangements efficiently can have a material effect on returns on capital, and therefore on how the market prices DOC relative to its peers.

Execution shortfalls in either area represent a monitoring point between reporting periods.

Policy and Reimbursement Risk: A Second-Order but Material Factor

Changes to Medicare and Medicaid reimbursement rates do not affect Healthpeak directly, but they do affect the financial health of its healthcare operator tenants — hospital systems, physician groups, and senior care operators. If reimbursement cuts reduce tenant revenues, the capacity of those tenants to meet lease obligations can deteriorate.

This second-order transmission mechanism is specific to healthcare real estate and distinguishes DOC's risk profile from that of commercial or industrial REITs. Regulatory developments in U.S. healthcare payment policy are therefore a relevant monitoring input for DOC traders.

Risk Summary Table

Traders accessing DOC price exposure through a prop trading or derivatives framework should factor all five dimensions into their analytical framework. No single driver operates in isolation — the interaction between rate direction and life-science sentiment, for example, can compound moves in either direction within a short window.

Note also that DOC follows scheduled trading sessions and is closed at weekends and on market holidays, meaning weekend gap risk is a real consideration when managing open positions into a Friday close.